Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
4 intermediate papers

Works of Luka de Vos being referenced

The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas
2020
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
2017

Author Peers

Author Last Decade Papers Cites
Luka de Vos 238 143 129 170 22 438
Sebastian Kłosek 164 126 53 100 18 450
Jinghui Hou 146 214 116 100 22 384
Siti Mazlipah Ismail 218 158 62 93 34 473
Sini Nurmenniemi 171 177 73 142 16 430
Shaohong Huang 230 177 62 185 34 479
Ambra V. Gualeni 218 193 62 158 19 464
Yunteng Wu 143 244 77 67 34 401
Changwen Zhai 199 87 32 140 22 384
Friederike Göke 274 182 57 85 23 506
Florence Cheung 212 168 33 130 18 484

All Works

Loading papers...

Rankless by CCL
2026